We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.34%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$55.7B
AUM Growth
-$11.4B
Cap. Flow
-$9.72B
Cap. Flow %
-17.45%
Top 10 Hldgs %
9.49%
Holding
4,137
New
382
Increased
1,324
Reduced
1,495
Closed
773

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$397M
2
YHOO
Yahoo Inc
YHOO
+$342M
3
BAC icon
Bank of America
BAC
+$322M
4
C icon
Citigroup
C
+$260M
5
BKNG icon
Booking.com
BKNG
+$219M

Sector Composition

Rank Sector Weight
1 Healthcare 13.78%
2 Technology 11.11%
3 Financials 10%
4 Consumer Discretionary 8.83%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STCN
3301
DELISTED
Steel Connect, Inc. Common Stock
STCN
$56K ﹤0.01%
4,049
+250
+7% +$4.51K
BTU
3302
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$56K ﹤0.01%
+24,122
New +$89.6K
KUST
3303
Kustom Entertainment Inc
KUST
$6.09M
0
NWBO
3304
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$52K ﹤0.01%
35,775
+14,780
+70% +$29.2K
PGNX
3305
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$50K ﹤0.01%
11,552
-2,707
-19% -$12.1K
PKD
3306
DELISTED
Parker Drilling Company
PKD
$48K ﹤0.01%
1,502
-1,382
-48% -$32.8K
SPCB icon
3307
SuperCom
SPCB
$67.9M
$46K ﹤0.01%
58
-3
-5% -$2.84K
ARRY
3308
DELISTED
Array Biopharma Inc
ARRY
$46K ﹤0.01%
15,428
-13,334
-46% -$40K
PWE
3309
DELISTED
Penn West Energy Petroleum Ltd
PWE
$46K ﹤0.01%
49,869
-10,500
-17% -$8.95K
CRC
3310
DELISTED
California Resources Corporation
CRC
$44K ﹤0.01%
4,253
-137,917
-97% -$1.63M
MTBL
3311
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$43K ﹤0.01%
8,667
-6,666
-43% -$31.7K
HIL
3312
DELISTED
Hill International, Inc. Common Stock
HIL
$43K ﹤0.01%
12,708
-4,388
-26% -$14.3K
GRPN icon
3313
PUT
Groupon
GRPN
$798M
$42K ﹤0.01%
+530
New +$36.6K
GOGL
3314
DELISTED
Golden Ocean Group
GOGL
$41K ﹤0.01%
+11,690
New +$40K
MNKD icon
3315
CALL
MannKind Corp
MNKD
$1.31B
$40K ﹤0.01%
5,000
MNKD icon
3316
PUT
MannKind Corp
MNKD
$1.31B
$40K ﹤0.01%
5,000
LSTA icon
3317
Lisata Therapeutics
LSTA
$15.9M
$37K ﹤0.01%
334
-461
-58% -$45.3K
HSTO
3318
DELISTED
Histogen Inc. Common Stock
HSTO
$34K ﹤0.01%
80
-234
-75% -$90.4K
FBP icon
3319
First Bancorp
FBP
$4.31B
$32K ﹤0.01%
11,125
-1,947
-15% -$5.19K
GLBL
3320
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$27K ﹤0.01%
11,275
SB icon
3321
Safe Bulkers
SB
$881M
$26K ﹤0.01%
+32,778
New +$19.3K
MTL
3322
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$25K ﹤0.01%
13,718
-3,001
-18% -$5.05K
TLRA
3323
DELISTED
Telaria, Inc.
TLRA
$24K ﹤0.01%
13,753
-74,989
-85% -$135K
CIVI
3324
DELISTED
Civitas Resources
CIVI
$22K ﹤0.01%
121
-3,265
-96% -$865K
GST
3325
DELISTED
Gastar Exploration Inc.
GST
$20K ﹤0.01%
18,311
+300
+2% +$310

Similar funds

David Shaw's Q1 2016 Portfolio in Review

As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.

  • David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
  • David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
  • David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
  • David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
  • David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
  • David Shaw opened 382 new positions and closed 773 in Q1 2016.
  • David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.